News

Walgreens, ESI bury hatchet. Now what?

BY Jim Frederick

So Walgreens and Express Scripts have buried the hatchet. The question is, can the nation’s top pharmacy retailer regain the billions of dollars in contracted prescription revenues it ceded to its competitors after the two sides severed relations in January? And, given the way Walgreens has adjusted and reset its growth strategy since then, does it matter that much?

The two companies announced July 19, in a rather tersely worded statement, that they had “reached a multiyear pharmacy network agreement that includes rates and terms” that both sides could live with, although those terms were not disclosed. By (apparently) resolving a nearly year-long dispute over reimbursement terms with ESI, the new agreement allows Walgreens to smudge out the line in the sand it drew with the powerful PBM — a stand that smaller, less powerful chains and independents applauded.

The deal ends an ugly chapter in the history of the sometimes strained relationship between retail pharmacies and the pharmacy benefit management industry. But undoing the damage done to both sides will take time.

Left unsaid, at least explicitly, is the fact that there’s nothing exclusive about the new contract. Walgreens’ 7,907 drug stores will simply swim in a vast pool of more than 64,000 pharmacies nationwide participating in what both sides call “the broadest Express Scripts retail pharmacy network available to new and existing clients.”

That means Walgreens will have to compete the old fashioned way: it will have to fight, market by market, to win back the millions of customers who were forced to shift their prescription business to competitors like CVS/pharmacy, Walmart, Rite Aid and a slew of other mass merchant, supermarket and regional pharmacy operators. It’s what Drug Store News senior editor Michael Johnsen a href="http://drugstorenews.com/article/walgreens-and-esis-new-deal-september-will-be-about-battle-pharmacy-patient">calls a “return to block and tackle mode”.

To a weaker or less vertically integrated drug retailer, that might pose a huge threat to future growth and viability. But we’re talking about Walgreens. The chain can bring to bear a huge arsenal of competitive and strategic weapons, including massive economies of scale, a strong balance sheet and, not least, the capability of plugging numerous holes in the nation’s leaky health care bucket via a 50-state network of retail and clinical pharmacies, workplace health centers, specialty pharmacy services and retail clinics.

How will it play out long term? Let us know your prediction by clicking the link below.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Diplomat ranks high in healthcare provider survey

BY Alaric DeArment

FLINT, Mich. — Nearly all healthcare professionals are satisfied with Diplomat Specialty Pharmacy’s services, according to results of a survey released Monday.

The privately owned specialty pharmacy company announced the results of its annual physician satisfaction survey, conducted by Gartner & Associates, showing that 98% of respondents were satisfied overall with Diplomat; 99% said the company met their expectations; and 91% said it exceeded the service levels of other pharmacies.

"This type of physician-provided data reinforces the importance and value of our approach to employee training and education," Diplomat CEO Phil Hagerman said. "Our increases in service levels are compelling and demonstrate that we are not putting growth in front of patient services and overall care. We believe that our industry-leading Diplomat University is helping to create a more knowledgeable, helpful and compassionate team of support staff."

 


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Green Forest Nutrition introduces Gummy Owls

BY Allison Cerra

SAN DIEGO — Green Forest Nutrition recently introduced a line of what it is touting as weight-loss gummies.

Gummy Owls are made with konjac mannan, a yam fiber that is designed to promote weight loss. The gummies are available in cherry, lemon, and strawberry flavors and are sugar free. Additional information can be found on the company’s website.

"Working together as a family to manage weight can be the push parents and children need to actually do it," Gummy Owls developer Lee Zhong said. "And Gummy Owls help the whole family: Those who are overweight can lose their extra fat, and those who are already fit won’t struggle to maintain their weight."

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?